1.De Baaij, JH, Hoenderop, JG & Bindels, RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95, 1–46.
2.Chakraborti, S, Chakraborti, T, Mandal, M, et al. (2002) Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 238, 163–179.
3.Mooren, FC (2015) Magnesium and disturbances in carbohydrate metabolism. Diabetes Obes Metab 17, 813–823.
4.Gröber, U, Schmidt, J & Kisters, K (2015) Magnesium in prevention and therapy. Nutrients 7, 8199–8226.
5.Joosten, MM, Gansevoort, RT, Mukamal, KJ, et al. (2013) Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 97, 1299–1306.
6.Del Gobbo, LC, Imamura, F, Wu, JH, et al. (2013) Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and metaanalysis of prospective studies. Am J Clin Nutr 98, 160–173.
7.Qu, X, Jin, F, Hao, Y, et al. (2013) Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLOS ONE 8, e57720.
8.Graham, LA, Caesar, JJ & Burgen, AS (1960) Gastrointestinal absorption and excretion of Mg 28 in man. Metabolism 9, 646–659.
9.King, DE, Mainous, AG III, Geesey, ME, et al. (2005) Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 24, 166–171.
10.Qu, X, Jin, F, Hao, Y, et al. (2013) Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLOS ONE 8, e57720.
11.Dong, JY, Xun, P, He, K, et al. (2011) Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 34, 2116–2122.
12.Bertinato, J, Wang, KC & Hayward, S (2017) Serum magnesium concentrations in the Canadian population and associations with diabetes, glycemic regulation, and insulin resistance. Nutrients 9, 3.
13.Guerrero-Romero, F & Rodríguez-Morán, M (2002) Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39, 209.
14.Chutia, H & Lynrah, KG (2015) Association of serum magnesium deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Physicians 7, 75–78.
15.Huerta, MG, Roemmich, JN, Kington, ML, et al. (2005) Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 28, 1175–1181.
16.Twig, G, Afek, A, Shamiss, A, et al. (2013) White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care 36, 276–282.
17.Wang, ZS, Song, ZC, Bai, JH, et al. (2013) Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus. Vasc Health Risk Manag 9, 237–243.
18.Lin, KD, Lee, MY, Feng, CC, et al. (2014) Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with type 2 diabetes. Diabet Med 31, 1341–1349.
19.Barazzoni, R, Gortan Cappellari, G, Semolic, A, et al. (2014) The association between hematological parameters and insulin resistance is modified by body mass index – results from the North-East Italy MoMa population study. PLOS ONE 9, e101590.
20.Van Orden, R, Eggett, DL & Franz, KB (2006) Influence of graded magnesium deficiencies on white blood cell counts and lymphocyte subpopulations in rats. Magnes Res 19, 93–101.
21.Khand, F, Shaikh, SS, Ata, MA, et al. (2015) Evaluation of the effect of smoking on complete blood counts, serum C-reactive protein and magnesium levels in healthy adult male smokers. J Pak Med Assoc 65, 59–61.
22.Johansson, HE, Haenni, A & Zethelius, B (2011) Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery. J Obes 2011, 273105.
23.Than, NN, Soe, HH, Palaniappan, SK, et al. (2017) Magnesium for treating sickle cell disease. Cochrane Database Syst Rev, issue 4, CD011358.
24.Bhoomika, MP, Raghunathan, S & Porwal, U (2014) Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus. Eur J Pharmacol 728, 128–134.
25.Nadler, JL, Shaw, S, Malayan, S, et al. (1992) Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 15, 835–841.
26.Rafieian-Kopaie, M & Nasri, H (2012) Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients. J Renal Inj Prev 1, 17–21.
27.Popkin, BM, Du, S, Zhai, F, et al. (2010) Cohort profile: the China Health and Nutrition Survey – monitoring and understanding socioeconomic and health change in China, 1989–2011. Int J Epidemiol 39, 1435–1440.
28.Alberti, KG, Zimmet, P, Shaw, J, et al. (2005) The metabolic syndrome – a new worldwide definition. Lancet 366, 1059–1062.
29.Russo, I, Traversa, M, Bonomo, K, et al. (2010) In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. Obesity (Silver Spring) 18, 788–797.
30.Scibior, A, Zaporowska, H & Ostrowski, J (2006) Selected haematological and biochemical parameters of blood in rats after subchronic administration of vanadium and/or magnesium in drinking water. Arch Environ Contam Toxicol 51, 287–295.
31.Ige, AO & Adewoye, EO (2017) Oral magnesium treatment reduces anemia and levels of inflammatory markers in experimental diabetes. J Diet Suppl 14, 76–88.
32.Zhang, H, Yang, Z, Zhang, W, et al. (2017) White blood cell subtypes and risk of type 2 diabetes. J Diabetes Complications 31, 31–37.
33.Salvagno, GL, Sanchis-Gomar, F, Picanza, A, et al. (2015) Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci 52, 86–105.
34.Czernichow, S, Zarebska, M, Preziosi, P, et al. (2004) Relationship between serum, red cell, urinary and dietary magnesium in a middle-aged French adult population. Int J Vitam Nutr Res 74, 123–128.
35.Sanchez-Morito, N, Planells, E, Aranda, P, et al. (2000) Influence of magnesium deficiency on the bioavailability and tissue distribution of iron in the rat. J Nutr Biochem 11, 103–108.
36.Shahbah, D, Hassan, T, Morsy, S, et al. (2017) Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia. Medicine (Baltimore) 96, e6352.
37.Lee, EY, Kim, SJ, Song, YJ, et al. (2013) Immature platelet fraction in diabetes mellitus and metabolic syndrome. Thromb Res 132, 692–695.
38.Stolic, RV, Jovanovic, AN, Trajkovic, GZ, et al. (2016) Is low magnesium a clue to arteriovenous fistula complications in hemodialysis? Int Urol Nephrol 48, 773–779.
39.Lu, L, Zhan, Y, Yu, J, et al. (2016) Prevalence of thrombocytopenia and its association with serum magnesium. Biol Trace Elem Res 169, 46–51.